The 2023 American Association of Clinical Endocrinology (AACE) position statement on GLP-1 therapy notes that FDA-approved agents should be the first-line choice when available, citing the quality controls embedded in the approval process [10]
Mertsalmi TH, Aho VTE, Pereira PAB, Paulin L, Pekkonen E, Auvinen P, Scheperjans F (2017) More than constipation - bowel symptoms in Parkinsons disease and their connection to gut microbiota
N-acetyl cysteine for treatment of autism, a case report
NAD+ NAD+ (Nicotinamide Adenine Dinucleotide) is a naturally occurring coenzyme found in every living cell
And it is far more common than most people realize
dapsone (a sulfone used in dermatology, leprosy, and Pneumocystis pneumonia prophylaxis) carries a high risk of haemolysis and should be avoided where possible [4] [11] Sulfonamides as a class, these carry haemolytic risk in G6PD deficiency